novo nordisk a/s-b (NOVOB:Copenhagen)
Ingelise Saunders Mph,BSc
Vice President of International Operations, Novo Nordisk A/S
|Age||Total Calculated Compensation||This person is connected to 40 board members in 7 different organizations across 13 different industries.|
See Board Relationships
Mrs. Ingelise Saunders, Mph, B.Sc. serves as the Chief Executive Officer of SLS Invest. Mrs. Saunders has been Chief Executive Officer of TD Vaccines A/S since November 2009 and serves as its President. She served as Chief Executive Officer of Action Pharma A/S since March 2010. She served as the Chief Executive Officer at Celltech Pharmaceuticals at Celltech Group Limited since March 2002. She served as Chief Executive Officer of UCB Pharma Limited. She served as Global ...
Novo AlléPhone: 45 44 44 88 88
Bagsvaerd, Capital Region of Denmark 2880
Fax: 45 44 49 05 55
Board Members Memberships*
Chief Executive Officer and Director
Chief Executive Officer, President and Director
Member of the Board
Former Chief Executive Officer of Celltech Pharmaceuticals
Independent Director, Member of Commercialisation & Business Development Committee for The Eu Territory and Member of Remuneration & Nomination Committee
Former Director and Member of Nomination & Compensation Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.6M||Compensation as of Fiscal Year 2013.|